CalciMedica, Inc.
CALC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534133
No open-market purchases or sales by CalciMedica, Inc. insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $8.39M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding CalciMedica, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 30 | 30 | 0 |
| Shares | 3.97M | 3.73M | −241.9K (−6.1%) |
| Value | $7.49M | $5.93M | −$1.57M (−20.9%) |
New holders (4)
Institutions that held CalciMedica, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sound View Wealth Advisors Group, LLC | 20,100 | $32.2K | 0.00% |
| Weaver Consulting Group | 13,393 | $21.4K | 0.01% |
| FMR LLC | 536 | $820 | 0.00% |
| BNP Paribas Arbitrage, SA | 19 | $30 | 0.00% |
Sold out (4)
Institutions that held CalciMedica, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| PVG Asset Management Corp | 30,385 | $58.0K |
| Cambridge Investment Research Advisors, Inc. | 23,539 | $45.0K |
| BlackRock, Inc. | 15,407 | $29.4K |
| JPMorgan Chase & Co | 15 | $29 |